Biopharmaceutical company developing therapeutics for orphan genetic diseases with a focus on neuromuscular disorders

Sectors
Healthcare
Life Sciences
First Invested
2012
Early
Company Status
IPO/Acquired
NASDAQ: RNA
Acquired by BioMarin